Gilead Sciences Invests in Research for COVID-19 Treatments for All Ages

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

Children are being hospitalized with COVID 19 at increasingly high rates, and those younger than 5 aren't eligible to receive a vaccine. We’re committed to helping in this area by investing in research for COVID-19 treatments for all ages.

About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences.

Tweet me: .@GileadSciences is committed to helping children being hospitalized with #COVID19 by investing in research for COVID-19 treatments for all ages. #CROI2022 https://bit.ly/3GNxutP

KEYWORDS: NASDAQ: GILD, COVID-19, CROI2022

Chart showing increase in COVID-19 hospitalizations among children in the US

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.60
-5.51 (-2.62%)
AAPL  266.96
+2.38 (0.90%)
AMD  194.77
-5.38 (-2.69%)
BAC  51.17
-1.89 (-3.55%)
GOOG  310.47
-4.43 (-1.41%)
META  636.88
-18.78 (-2.86%)
MSFT  383.65
-13.58 (-3.42%)
NVDA  190.53
+0.72 (0.38%)
ORCL  139.89
-8.19 (-5.53%)
TSLA  395.13
-16.69 (-4.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.